A client presents to the healthcare setting with a diagnosis of emphysema. Which of the following medications would be contraindicated with the client's allergy to soybeans?

Choice A reason: Ipratropium bromide (Atrovent) is an anticholinergic bronchodilator often used to treat chronic obstructive pulmonary disease (COPD), including emphysema. However, it contains soy lecithin, which can cause allergic reactions in individuals with soy allergies. Therefore, ipratropium bromide is contraindicated for patients with soy allergies due to the risk of an allergic reaction. Choice B reason: Albuterol (Ventolin) is a short-acting beta-agonist used to relieve bronchospasm in conditions like asthma and COPD. It does not contain soy-based ingredients, making it a safe option for individuals with soy allergies. Therefore, albuterol is not contraindicated in patients with a soy allergy. Choice C reason: Methylprednisolone (Solumedrol) is a corticosteroid used to reduce inflammation in various conditions, including severe asthma and COPD exacerbations. It does not contain soy-based ingredients, making it safe for patients with soy allergies. Therefore, methylprednisolone is not contraindicated for individuals with a soy allergy. Choice D reason: Montelukast (Singulair) is a leukotriene receptor antagonist used to manage asthma and allergic rhinitis. It does not contain soy-based ingredients, so it is safe for patients with soy allergies. Therefore, montelukast is not contraindicated for individuals with a soy allergy.